Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Evaluating a new brush for treating blepharitis

Official title: Evaluation of SUMMIT BRUSH in Treatment of Blepharitis

Run by University of Notre Dame · NCT04603222 · Data updated 2026-11-12

This study is testing a new brush combined with a regular eyelid cleanser to see if it helps people with blepharitis feel better and reduce dry eye symptoms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Notre Dame
Academic / other
Locations3 sites (Boulder, Colorado and 2 other locations)
StatusRecruiting
StartedJuly 21, 2020
Main results expectedOctober 24, 2021
Study endsJuly 18, 2022
Registry record updatedNovember 27, 2020
Trial IDNCT04603222 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals exhibiting clinical signs of blepharitis, such as visible collarettes and scurfs on the eyelid margins.

Probably not a fit

Patients with conditions like hordeolum, chalazion, or acute bacterial conjunctivitis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of the SUMMIT BRUSH, a new self-administered disposable ocular brush, in conjunction with a commonly prescribed eyelid cleanser for treating blepharitis, a major cause of Dry Eye Disease. The study aims to determine if this combination is more effective at removing eyelid debris compared to standard treatments. Participants will be assessed for clinical signs and symptoms of blepharitis, and the trial will involve the use of slit lamp biomicroscopy to evaluate treatment outcomes.

Why it matters

Potential benefit: If successful, this approach could provide a more effective and convenient treatment option for patients suffering from blepharitis.

How similar studies have gone: While there have been studies on eyelid cleansers, the specific use of the SUMMIT BRUSH in this context is a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical signs and symptoms of blepharitis (Staphylococcal and Demodex).
* Must exhibit visible collarettes, clear sleeves, and scurfs on the eyelid margins upon Slit Lamp Biomicroscopy.

Exclusion Criteria:

* Hordeolum
* Chalazion
* Periorbital cellulitis
* Allergic eyelid dermatitis.
* Acute bacterial conjunctivitis
* Open periorbital wounds.

Where it's running

  • University of Colorado
    Boulder, Colorado, United States
    Recruiting
  • Michiana Eye Center
    Mishawaka, Indiana, United States
    Recruiting
  • Kentucky Eye Institute
    Lexington, Kentucky, United States
    Recruiting

Study contacts

  • Principal investigator: Giles E Duffield, Ph.D. — University of Notre Dame
  • Study coordinator: Giles E Duffield, Ph.D.
  • Email: duffield.2@nd.edu
  • Phone: 5746311834

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.